Medicine (Oct 2023)
Clinical Epidemiology, Illness Profiles, and the Implication of COVID-19 Before and After the Nationwide Omicron Outbreak During the Winter of 2022
- Yuming Guo,
- Zhe Xu,
- Wen-Xin Wang,
- Cheng Zhen,
- Jinhua Hu,
- Jinsong Mu,
- Chengcheng Ji,
- Xin Yuan,
- Ruonan Xu,
- Lei Huang,
- Lei Shi,
- Fanping Meng,
- Junliang Fu,
- Shuangnan Zhou,
- Siyu Wang,
- Fengyi Li,
- Bo Tu,
- Dawei Zhang,
- Huihuang Huang,
- Yufeng Mao,
- Wen Xu,
- Chao Zhang,
- Xiuying Mu,
- Jun Zhao,
- Bo Jin,
- Haibin Su,
- Yinying Lu,
- Yongqian Cheng,
- Dong Ji,
- Shaoli You,
- Jinghui Dong,
- Changchun Liu,
- Mengmeng Zhang,
- Yuanyuan Li,
- Tianjun Jiang,
- Yonggang Li,
- Fu-Sheng Wang,
- Haijuan Wang
Affiliations
- Yuming Guo
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Zhe Xu
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Wen-Xin Wang
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Cheng Zhen
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Jinhua Hu
- 2 Senior Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China
- Jinsong Mu
- 3 Institute of Intensive Care Unit, the Fifth Medical Center of Chinese PLA Hospital, Beijing 100039, China
- Chengcheng Ji
- 3 Institute of Intensive Care Unit, the Fifth Medical Center of Chinese PLA Hospital, Beijing 100039, China
- Xin Yuan
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Ruonan Xu
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Lei Huang
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Lei Shi
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Fanping Meng
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Junliang Fu
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Shuangnan Zhou
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Siyu Wang
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Fengyi Li
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Bo Tu
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Dawei Zhang
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Huihuang Huang
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Yufeng Mao
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Wen Xu
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Chao Zhang
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Xiuying Mu
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Jun Zhao
- 2 Senior Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China
- Bo Jin
- 2 Senior Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China
- Haibin Su
- 2 Senior Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China
- Yinying Lu
- 4 Comprehensive Liver Cancer, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China
- Yongqian Cheng
- 5 Department of Geriatrics, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China
- Dong Ji
- 2 Senior Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China
- Shaoli You
- 2 Senior Department of Hepatology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China
- Jinghui Dong
- 6 Department of Radiology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
- Changchun Liu
- 6 Department of Radiology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
- Mengmeng Zhang
- 6 Department of Radiology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
- Yuanyuan Li
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Tianjun Jiang
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Yonggang Li
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Fu-Sheng Wang
- 1 Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China
- Haijuan Wang
- DOI
- https://doi.org/10.1097/ID9.0000000000000101
- Journal volume & issue
-
Vol. 3,
no. 4
pp. 176 – 185
Abstract
Abstract. Background. The outbreak and prevalence of the Omicron variant have threatened human health since March 2022 in mainland China. In this study, we aimed to investigate the clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) in the Beijing region. Methods. In this retrospective study, we enrolled inpatients admitted for COVID-19 in the Fifth Medical Center of Chinese PLA General Hospital in Beijing between November 10, 2022, and January 30, 2023. Demographic and clinical features and treatment outcomes were comprehensively analyzed. We used logistic regression and linear regression analyses to explore the risk factors associated with disease severity and time of nucleic acid conversion, respectively. Results. A total of 1010 hospitalized patients with COVID-19 were enrolled. The median age was 43.0 years (interquartile range, 28.0–63.0), and patients aged 7 pg/mL, lactic dehydrogenase level >245 U/L, cough, and fever at admission. Age ≥80 years and chronic lung disease were independent risk factors in the nonmild group in elderly patients. In addition, the duration for nucleic acid to turn negative was approximately 5.0 d (interquartile range, 3.0–7.0). Prolonged time of nucleic acid conversion was associated with age ≥60 years, serum urea nitrogen level >8.2 mmol/L, neutrophil count >7 ×109/L, and the presence of a chronic lung disease or carcinoma. Finally, unvaccinated patients accounted for 37.3% of enrolled patients; children and the elder people accounted for approximately half of that. The univariable analysis found that booster doses reduced disease severity and shortened the time of nucleic acid conversion in elderly patients. Conclusions. The outbreak of Omicron rapidly increased the number of patients with COVID-19 in Beijing. In elderly patients, booster doses may reduce disease severity and shorten the time of nucleic acid conversion. Healthcare systems should be optimized before an emerging epidemic outbreak.